ARK Genomic Revolution ETF
ARK Genomic Revolution ETF reported 30 holdings worth US$1.56B as of Jul 31, 2026 (Form N-PORT)
As of Jul 31, 2026 · Filed Sep 22, 2026
ARK Genomic Revolution ETF reported 30 holdings worth US$1.56B as of Jul 31, 2026. Largest: 10x Genomics, Inc., Twist Bioscience Corporation and Tempus Ai, Inc. Filed Sep 22, 2026 (Form N-PORT).
- Holdings
- 30
- Value as reported
- US$1.56B
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| 10x Genomics, Inc. | 3.09M | US$146M | 9.4% |
| Twist Bioscience Corporation | 1.31M | US$120M | 7.7% |
| Tempus Ai, Inc. | 2.33M | US$102M | 6.6% |
| Crispr Therapeutics Ag | 2.04M | US$97.9M | 6.3% |
| Personalis, Inc. | 6.73M | US$85.3M | 5.5% |
| Absci Corporation | 10.3M | US$80M | 5.1% |
| Guardant Health, Inc. | 456K | US$73.8M | 4.7% |
| Illumina, Inc. | 360K | US$73.8M | 4.7% |
| Eli Lilly And Company | 63,502 | US$73M | 4.7% |
| Caredx, Inc. | 1.53M | US$66.9M | 4.3% |
| Natera, Inc. | 240K | US$64.3M | 4.1% |
| Beam Therapeutics Inc. | 2.3M | US$58.8M | 3.8% |
| Recursion Pharmaceuticals, Inc. | 13.6M | US$40.9M | 2.6% |
| Adaptive Biotechnologies Corporation | 1.77M | US$40.1M | 2.6% |
| Veracyte, Inc. | 856K | US$39.7M | 2.5% |
| Nurix Therapeutics, Inc. | 1.68M | US$39M | 2.5% |
| Butterfly Network, Inc. | 4.77M | US$33.9M | 2.2% |
| Schrodinger, Inc. | 2.04M | US$30.9M | 2.0% |
| Genedx Holdings Corp. | 447K | US$29.1M | 1.9% |
| Intellia Therapeutics, Inc. | 2.67M | US$28.5M | 1.8% |
| Ionis Pharmaceuticals, Inc. | 532K | US$27.5M | 1.8% |
| Alamar Biosciences, Inc. | 957K | US$24.3M | 1.6% |
| Prime Medicine, Inc. | 7.51M | US$21.9M | 1.4% |
| Generate Biomedicines, Inc. | 1.24M | US$17.3M | 1.1% |
| Arcturus Therapeutics Holdings Inc. | 2.74M | US$15.8M | 1.0% |
| Cerus Corporation | 7.22M | US$15.5M | 1.00% |
| 908 Devices Inc. | 1.91M | US$15.3M | 0.98% |
| Pacific Biosciences Of California, Inc. | 10.6M | US$14.9M | 0.96% |
| Ataibeckley Inc. | 1.64M | US$11.8M | 0.76% |
| Quantum-si Incorporated | 6.76M | US$4.82M | 0.31% |
Source
View original at SEC
Related